We are live on ! Find out more
BPC

Banque Pictet & Cie Portfolio holdings

AUM $16B
1-Year Est. Return 29.1%
This Fund
S&P 500
This Quarter Est. Return
-6.43%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$12.9B
AUM Growth
-$560M
Cap. Flow
+$558M
Cap. Flow %
4.31%
Top 10 Hldgs %
51.42%
Holding
672
New
56
Increased
213
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
MCO icon
Moody's
MCO
+$25.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$23.8M
3
SOPH icon
SOPHiA GENETICS
SOPH
+$23.6M
4
AMZN icon
Amazon
AMZN
+$23.1M
5
ZTS icon
Zoetis
ZTS
+$17M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$307M
2
LPX icon
Louisiana-Pacific
LPX
+$25.1M
3
TSLA icon
Tesla
TSLA
+$21.4M
4
NVCR icon
NovoCure
NVCR
+$18.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$14.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.18%
2 Healthcare 17.7%
3 Communication Services 10.57%
4 Technology 9.47%
5 Financials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
76
JPMorgan Chase
JPM
$962B
$20M 0.15%
146,969
-9,333
-6% -$1.38M
DXCM icon
77
DexCom
DXCM
$33.8B
$19.6M 0.15%
153,176
+17,520
+13% +$1.92M
LOGI icon
78
Logitech
LOGI
$14.8B
$19.5M 0.15%
259,629
+102
+0% +$7.91K
MDLZ icon
79
Mondelez International
MDLZ
$78.9B
$19.1M 0.15%
304,580
-21,633
-7% -$1.41M
LYB icon
80
LyondellBasell Industries
LYB
$20.7B
$18.8M 0.15%
182,776
-5,302
-3% -$529K
IDXX icon
81
Idexx Laboratories
IDXX
$46.2B
$18.6M 0.14%
34,075
-842
-2% -$443K
NEM icon
82
Newmont
NEM
$124B
$18.6M 0.14%
233,928
-270
-0.1% -$18.3K
ZBH icon
83
Zimmer Biomet
ZBH
$18.5B
$18.3M 0.14%
142,905
+7,999
+6% +$964K
AMED
84
DELISTED
Amedisys
AMED
$17.9M 0.14%
103,829
+35,525
+52% +$5.31M
EW icon
85
Edwards Lifesciences
EW
$54B
$17M 0.13%
144,765
-10,254
-7% -$1.15M
SOPH icon
86
SOPHiA GENETICS
SOPH
$638M
$16.2M 0.13%
+2,096,420
New +$23.6M
QQQ icon
87
Invesco QQQ Trust
QQQ
$478B
$15.7M 0.12%
43,240
-472
-1% -$168K
BSX icon
88
Boston Scientific
BSX
$74.2B
$15.2M 0.12%
342,595
-34,951
-9% -$1.51M
C icon
89
Citigroup
C
$228B
$15.1M 0.12%
283,327
-14,852
-5% -$917K
VGK icon
90
Vanguard FTSE Europe ETF
VGK
$31B
$14.8M 0.11%
237,459
-13,535
-5% -$868K
ADSK icon
91
Autodesk
ADSK
$53.1B
$14M 0.11%
65,354
+39,438
+152% +$9.08M
AZN icon
92
AstraZeneca
AZN
$246B
$13.2M 0.1%
99,219
-865
-0.9% -$104K
PFE icon
93
Pfizer
PFE
$152B
$13.1M 0.1%
253,022
+13,970
+6% +$725K
GDX icon
94
VanEck Gold Miners ETF
GDX
$27.5B
$13M 0.1%
339,171
-33,622
-9% -$1.14M
GMED icon
95
Globus Medical
GMED
$11.4B
$12.6M 0.1%
171,226
-9,524
-5% -$662K
BIIB icon
96
Biogen
BIIB
$30.1B
$12.6M 0.1%
59,639
-17,442
-23% -$3.79M
WDAY icon
97
Workday
WDAY
$44.8B
$12.4M 0.1%
51,877
-453
-0.9% -$108K
IWM icon
98
iShares Russell 2000 ETF
IWM
$81.8B
$12.4M 0.1%
60,302
-2,457
-4% -$501K
HCA icon
99
HCA Healthcare
HCA
$89.1B
$12.3M 0.1%
49,212
+6,187
+14% +$1.55M
INDA icon
100
iShares MSCI India ETF
INDA
$6.6B
$12.3M 0.09%
275,607
+1,213
+0.4% +$54.3K
2 3
4
5 6

Similar funds

MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCIP
Life Cycle Investment Partners London $15.7B AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Banque Pictet & Cie's Q1 2022 Portfolio in Review

As of Q1 2022, Banque Pictet & Cie held 672 positions worth $12.9B, down 4.1% from $13.5B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Banque Pictet & Cie deployed $558M of net new capital in Q1 2022, opening 56 new positions and adding to 213 existing holdings. Its largest new stake was SOPHiA GENETICS: 2,096,420 shares worth $16.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $307M trimmed.

  • Banque Pictet & Cie's largest Q1 2022 buy was SOPHiA GENETICS: 2,096,420 shares worth $16.2M.
  • Banque Pictet & Cie added most to Moody's in Q1 2022, an estimated $25.9M increase.
  • Banque Pictet & Cie's biggest Q1 2022 reduction was Johnson & Johnson, cutting an estimated $307M.
  • Banque Pictet & Cie fully exited Louisiana-Pacific in Q1 2022, selling an estimated $25.1M.
  • Banque Pictet & Cie's ten largest holdings make up 51% of its $12.9B portfolio in Q1 2022.
  • Banque Pictet & Cie opened 56 new positions and closed 50 in Q1 2022.
  • Banque Pictet & Cie's portfolio value fell 4.1% quarter-over-quarter to $12.9B.

Based on Banque Pictet & Cie's 13F filing for Q1 2022, filed 4 May 2022.